|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
1R01CA128943-01A2
|
$344,450
|
$344,450
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$117,817
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
1R01CA131421-01A2
|
$310,005
|
$155,003
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression
|
5R01CA131914-02
|
$233,704
|
$233,704
|
LI, XIAOTAO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Signaling Pathways in Proliferation and Differentiation
|
5R01CA065842-15
|
$423,810
|
$423,810
|
EWEN, MARK
|
DANA-FARBER CANCER INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-47S1
|
$126,362
|
$3,791
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S2
|
$250,000
|
$7,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S3
|
$100,000
|
$3,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-47
|
$7,507,885
|
$225,237
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Preoperative and follow-up tests for thyroid tumors
|
4R33CA113461-02
|
$277,131
|
$277,131
|
RIGGINS, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
|
Dose-Response in Radionuclide Therapy
|
5R01CA116477-04
|
$397,575
|
$131,200
|
SGOUROS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Events in the PI3K/Akt Pathway in Thyroid Cancer
|
1R01CA134225-01A2
|
$332,332
|
$332,332
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Genetic and Epigenetic Events in Papillary Thyroid Cancer
|
5R01CA113507-04
|
$282,659
|
$282,659
|
XING, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Molecular Classification of Suspicious Thyroid Tumors
|
5R01CA107247-05
|
$307,116
|
$307,116
|
ZEIGER, MARTHA
|
JOHNS HOPKINS UNIVERSITY
|
|
A novel osteopontin fragment as a diagnostic/prognostic cancer plasma biomarker
|
5R21CA129849-02
|
$202,902
|
$101,451
|
Liaw, Lucy
|
MAINE MEDICAL CENTER
|
|
Modelling BRaf-dependent thyroid cancer in the mouse
|
1F32CA142150-01
|
$59,402
|
$59,402
|
McFadden, David
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
A Drosophila Model for MEN2 and Sporadic MTCs
|
5R01CA084309-10
|
$236,780
|
$236,780
|
Cagan, Ross
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$774,176
|
$38,709
|
Alavanja
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$115
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$17,295
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04150
|
$62,859
|
$1,886
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04175
|
$30,597
|
$12,239
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10430
|
$103,605
|
$103,605
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10441
|
$63,699
|
$12,740
|
Berrington, Amy
|
DCEG (NCI)
|
|
Risk factors for thyroid cancer in the NCI cohorts
|
ZIA CP010136-10447
|
$50,433
|
$50,433
|
Berrington
|
DCEG (NCI)
|
|
Dosimetry Projects
|
ZIA CP010133-04041
|
$285,181
|
$228,144
|
Bouville
|
DCEG (NCI)
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010120-02135
|
$102,894
|
$9,260
|
Cantor, Kenneth
|
DCEG (NCI)
|
|
Preclinical Mouse Model of Thyroid Carcinogenesis
|
ZIA BC 011191
|
$532,506
|
$426,005
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$684,129
|
$34,206
|
Chow
|
DCEG (NCI)
|
|
Adrenocortical Cancer and Thyroid Carcinomas: Models with Unique Properties
|
ZIA BC 010626
|
$272,627
|
$136,314
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$220,828
|
Fojo, Antonio
|
CCR (NCI)
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$43,418
|
$4,342
|
Hornyak, Thomas
|
CCR (NCI)
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$109,726
|
$54,863
|
Kelly, Kathleen
|
CCR (NCI)
|
|
Thyroid Stem/Progenitor Cells
|
ZIA BC 005522
|
$447,218
|
$447,218
|
Kimura, Shioko
|
CCR (NCI)
|
|
Cancer risk in x-ray technologists
|
ZIA CP010133-04180
|
$1,340,943
|
$201,141
|
Linet
|
DCEG (NCI)
|
|
Chornobyl Thyroid Study (Belarus)
|
ZIA CP010132-04019
|
$484,069
|
$484,069
|
Mabuchi
|
DCEG (NCI)
|
|
Chornobyl Thyroid Study (Ukraine)
|
ZIA CP010132-04173
|
$853,931
|
$853,931
|
Mabuchi
|
DCEG (NCI)
|
|
Study to improve thyroid doses from fallout exposure in Kazakhstan
|
ZIA CP010132-10395
|
$302,600
|
$302,600
|
Mabuchi
|
DCEG (NCI)
|
|
Studies of Atomic Bomb Survivors
|
ZIA CP010134-04016
|
$480,282
|
$24,014
|
Mabuchi, Kiyohitko
|
DCEG (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$287,498
|
$11,500
|
Merino, Maria
|
CCR (NCI)
|
|
Bioterrorism Studies
|
ZIA CP010185-10027
|
$302,600
|
$151,300
|
S Linet, Martha
|
DCEG (NCI)
|
|
Prospective Studies of Diet and Cancer in the AARP Cohort
|
ZIA CP010196-03152
|
$1,665,672
|
$83,284
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010125-10347
|
$19,130
|
$1,913
|
Ward, Mary
|
DCEG (NCI)
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010125-10472
|
$2,944
|
$2,944
|
Ward, Mary
|
DCEG (NCI)
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010125-10473
|
$42,741
|
$42,741
|
Ward, Mary
|
DCEG (NCI)
|
|
Cancer Risk and Environmental Exposures
|
ZIA CP010125-10474
|
$12,664
|
$3,166
|
Ward, Mary
|
DCEG (NCI)
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-34S1
|
$89,606
|
$6,272
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-34
|
$3,956,712
|
$276,970
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
|
5P01CA124570-02
|
$2,398,547
|
$2,398,547
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Thyroid for this search: $14,734,348
|